EPOGEN- epoetin alfa solution 
Amgen Inc



Epogen® (Ee-po-jen)
(epoetin alfa)

Read this Medication Guide:

This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or your treatment. Talk with your healthcare provider regularly about the use of Epogen and ask if there is new information about Epogen.

What is the most important information I should know about Epogen?      

Epogen may cause serious side effects that can lead to death, including: 

For people with cancer:

For all people who take Epogen, including people with cancer or chronic kidney disease:

See “What are the possible side effects of Epogen?” below for more information.

If you decide to take Epogen, your healthcare provider should prescribe the smallest dose of Epogen that is necessary to reduce your chance of needing RBC transfusions.

What is Epogen?

Epogen is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Epogen works like the human protein called erythropoietin to help your body make more RBCs. Epogen is used to reduce or avoid the need for RBC transfusions.

Epogen may be used to treat anemia if it is caused by:

Epogen may also be used to reduce the chance you will need RBC transfusions if you are scheduled for certain surgeries where a lot of blood loss is expected.

If your hemoglobin level stays too high or if your hemoglobin goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take Epogen, even if you do not have an increase in your hemoglobin level.

Epogen should not be used for treatment of anemia:

Epogen has not been proven to improve quality of life, fatigue, or well-being.

Epogen should not be used to reduce the chance of RBC transfusions if:

Who should not take Epogen?

Do not take Epogen if you:

Do not give Epogen from multiple-dose vials to:

What should I tell my healthcare provider before taking Epogen?

Epogen may not be right for you. Tell your healthcare provider about all your health conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of your medicines with you and show it to your healthcare provider when you get a new medicine.

How should I take Epogen?

What are the possible side effects of Epogen?

Epogen may cause serious side effects.

Common side effects of Epogen include:

These are not all of the possible side effects of Epogen. Your healthcare provider can give you a more complete list. Tell your healthcare provider about any side effects that bother you or that do not go away.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Epogen?

Keep Epogen and all medicines out of the reach of children.

General information about Epogen

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Use Epogen only for the condition for which it has been prescribed. Do not give Epogen to other patients even if they have the same symptoms that you have. It may harm them.

This Medication Guide summarizes the most important information about Epogen. If you would like more information about Epogen, talk to your healthcare provider.  You can ask your healthcare provider or pharmacist for information about Epogen that is written for healthcare professionals. For more information, go to the following website: www.epogen.com or call 1-800-77-AMGEN.

What are the ingredients in Epogen?

Active Ingredient: epoetin alfa

Inactive Ingredients: 

This Medication Guide has been approved by the U.S. Food and Drug Administration.

Manufactured by:

Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 U.S.A.

Revised: 4/2017

©1989-2017 Amgen Inc. All rights reserved.

1xxxxxx- v7                                                            

Revised: 4/2017
Amgen Inc